NTUC Income Partners Plug and Play to Create Financial Access within Digital Ecosystems in the Region
SINGAPORE, March 22, 2022 /PRNewswire/ -- Plug and Play, a global startup accelerator and corporate innovation platform headquartered in Silicon Valley, and NTUC Income (Income), a leading composite insurer in Singapore, announced today that the latter will be a corporate partner of Plug and Play APAC's Insurtech program. The strategic partnership, which spans across Southeast Asia, will see Income...
Ascentage Pharma’s MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Rare Pediatric Disease Designation by the US FDA for the Treatment of Neuroblastoma
SUZHOU, China, and ROCKVILLE, MD, March 22, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its novel MDM2-p53 inhibitor, alrizomadlin (APG-115), was granted a Rare Pediatric Disease (RPD) designation by the US Food and...
Milltrust Ventures to Invest in First-In-Class Health Tech Platform Oncoshot
SINGAPORE, March 22, 2022 /PRNewswire/ – Oncoshot has announced it will be welcoming Dr Bernard Ng, Chief Scientific Officer of Milltrust Ventures, to its advisory board this month. This comes as a first step as the specialist investment organization finances the fast-growing health tech company founded in Singapore. Milltrust Ventures is a subsidiary of Milltrust International Group, a specialist...
Transcenta Announces Global Clinical Collaboration with Bristol Myers Squibb to Evaluate TST001 in Combination with Opdivo® in Patients with Locally Advanced or Metastatic Gastric / Gastroesophageal Junction Cancer
SUZHOU, China, March 22, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it has established a global clinical collaboration with Bristol Myers Squibb to evaluate the combination of TST001, an investigational humanized monoclonal antibody targeting Claudin18.2 developed by Transcenta,...
CAS applies AI-driven approach in collaboration with INPI Brazil to transform patent examinations
Innovation contributes to reducing application backlog in Latin America's biggest economy by 80% COLUMBUS, Ohio, March 22, 2022 /PRNewswire/ -- CAS, a division of the American Chemical Society, recently completed a major project with The National Institute of Industrial Property (INPI) of Brazil to implement an enhanced examination workflow solution for chemistry...
Transnetyx Announces Acquisition of a-tune
MEMPHIS, Tenn., March 22, 2022 /PRNewswire/ -- Transnetyx, a global leader in outsourced genetic services, announced the acquisition of a-tune, a best-in-class software for animal research and compliance. This acquisition allows Transnetyx to partner with a-tune to further streamline animal research facility operations, simplify data management, and save time and money...
Cali Biosciences Announces Successful Results in Phase IIb Study of Long-Acting Ropivacaine (CPL-01) for Non-Opioid Treatment of Post-Operative Pain
SAN DIEGO, March 22, 2022 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali Biosciences"), a biopharmaceutical company focused on the research and development of innovative drugs, announced successful results in its Phase IIb study of its perioperative long-acting analgesic product CPL-01. CPL-01 is an extended-release injectable version of Naropin® (ropivacaine hydrochloride), developed by Cali Biosciences to treat post-operative...
Ascentage Pharma Announces 2021 Annual Results with Commercialization Programs Going Full Steam Ahead
SUZHOU, China and ROCKVILLE, Md., March. 21, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released its annual results for full year 2021, during which the company achieved significant progress realizing its vision of global innovation...
BIOKANGTAI Signs a Cooperation Agreement with the Largest Importer of Parenteral Products in Philippines
SHENZHEN, China, March 21, 2022 /PRNewswire/ -- On March 17, 2022, Shenzhen Kangtai Biological Products Co., Ltd signed a framework agreement with Phil.PharmaWealth Inc., the largest importer of Parenteral Products in Philippines, and both parties reached an agreement on jointly promoting the registration application and commercial sales of BIOKANGTAI's 23-valent pneumococcal polysaccharide vaccine in Philippines. BIOKANGTAI's 23-valent pneumococcal polysaccharide...
3billion to reveal its diagnostic performance at ACMG annual meeting 2022
SEOUL, South Korea, March 21, 2022 /PRNewswire/ -- 3billion announced that Chief Medical Officer Dr. Go Hun Seo will introduce a research poster at ACMG annual meeting 2022, held in Nashville, TN, from March 22 through 26. This poster highlights the importance of continuous reanalysis for undiagnosed patients. In a previous single-center pilot study, Dr. Seo introduced...
